EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Vasopressin V1a receptor and oxytocin receptor regulate murine sperm motility differently

Hiroyoshi Tsuchiya iD, Masakatsu Fujinoki, Morio Azuma, Taka-Aki Koshimizu

Life Science Alliance · 2023

DOI: 10.26508/lsa.202201488 ↗

At a glance

Journal article in Life Science Alliance, 2023. Written by Hiroyoshi Tsuchiya and 3 co-authors. Institution: Division of Molecular Pharmacology, Department of Pharmacology, Jichi Medical University, Shimotsuke, Japan tutty@jichi.ac.jp. Major MEDLINE topics: Receptors, Oxytocin, Receptors, Vasopressin. Cited 3 times so far (Crossref); 89 references. The full text is freely available (open access, CC BY 4.0). Funded by: Ministry of Education, Culture, Sports, Science and Technology, Kowa Life Science Foundation, JKA Foundation.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Specific receptors for the neurohypophyseal hormones, arginine vasopressin (AVP) and oxytocin, are present in the male reproductive organs. However, their exact roles remain unknown. To elucidate the physiological functions of pituitary hormones in male reproduction, this study first focused on the distribution and function of one of the AVP receptors, V1a. In situ hybridization analysis revealed high expression of the Avpr1a in Leydig cells of the testes and narrow/clear cells in the epididymis, with the expression pattern differing from that of the oxytocin receptor (OTR). Notably, persistent motility and highly proportional hyperactivation were observed in spermatozoa from V1a receptor–deficient mice. In contrast, OTR blocking by antagonist atosiban decreased hyperactivation rate. Furthermore, AVP stimulation could alter the extracellular pH mediated by the V1a receptor. The results highlight the crucial role of neurohypophyseal hormones in male reproductive physiology, with potential contradicting roles of V1a and OTR in sperm maturation. Our findings suggest that V1a receptor antagonists are potential therapeutic drugs for male infertility.

Subjects

MeSH terms (MEDLINE)

Receptors, OxytocinReceptors, VasopressinMaleMiceAnimalsSperm MotilitySemenOxytocinArginine Vasopressin

Substances

Receptors, OxytocinReceptors, VasopressinOxytocinArginine Vasopressin

Authors and institutions

  • Division of Molecular Pharmacology, Department of Pharmacology, Jichi Medical University, Shimotsuke, Japan tutty@jichi.ac.jp.
  • Research Center for Laboratory Animals, Comprehensive Research Facilities for Advanced Medical Science, School of Medicine, Dokkyo Medical University, Mibu, Japan.
  • Division of Molecular Pharmacology, Department of Pharmacology, Jichi Medical University, Shimotsuke, Japan.

ORCID profiles: Hiroyoshi Tsuchiya

Funding

  • Ministry of Education, Culture, Sports, Science and Technology
  • Kowa Life Science Foundation
  • JKA Foundation
  • Japan Private School Promotion Foundation

Cite

APA

Tsuchiya, H., Fujinoki, M., Azuma, M., & Koshimizu, T. A. (2023). Vasopressin V1a receptor and oxytocin receptor regulate murine sperm motility differently. Life Science Alliance. https://doi.org/10.26508/lsa.202201488

Vancouver

Tsuchiya H, Fujinoki M, Azuma M, Koshimizu TA. Vasopressin V1a receptor and oxytocin receptor regulate murine sperm motility differently. Life Science Alliance. 2023. doi:10.26508/lsa.202201488

BibTeX
@article{Tsuchiya2023,
  author = {Tsuchiya, Hiroyoshi and Fujinoki, Masakatsu and Azuma, Morio and Koshimizu, Taka-Aki},
  title = {Vasopressin V1a receptor and oxytocin receptor regulate murine sperm motility differently},
  journal = {Life Science Alliance},
  year = {2023},
  doi = {10.26508/lsa.202201488}
}
Start for free →